Neel R. Gandhi, M.D is an Infectious Disease Epidemiologist and Physician, and Professor of Epidemiology at Emory University’s Rollins School of Public Health. Dr. Gandhi’s research has focused on tuberculosis (TB) infection and disease in low- and middle-income countries since 1998. Read more
Since 2002, Dr Gandhi has maintained a study site in South Africa where he has conducted clinical research studies characterizing the transmission and epidemiology of TB and drug-resistant TB in a setting with a high prevalence of HIV co-infection. He has also engaged in translational studies examining immunologic and genetic factors that influence individual susceptibility to Mycobacterium tuberculosis infection, with study sites in Kenya, Ethiopia, Brazil, and India. Dr. Gandhi’s research group has conducted seminal studies demonstrating that transmission of drug-resistant TB strains is a dominant factor driving the rapid expansion of the epidemic. They have also shown that individuals co-infected with drug-resistant TB and HIV can be safely and successfully treated when TB medications and antiretroviral therapy are given concurrently. His group is now investigating transmission of TB through casual contact, resistance to bedaquiline and other new TB medicines, and genetic and immunologic factors associated with TB infection and disease.
